Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Sen. Rand Paul Talks US Debt, ICE, Future of DHS
12:21

Uber and Zoox CEOs Talk Robotaxi Partnership
08:35

Former St Louis Fed President Jim Bullard Talks Warsh's Nomination Process
05:53